Keros Therapeutics, Inc. (KROS) Revenue 2019–2025
Keros Therapeutics, Inc. (KROS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$244.1MFY2025 · since FY2019: $10.0M → $244.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $244.1M | +6775.0% |
| FY2024 | $3.5M | +2251.0% |
| FY2023 | $151,000 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $20.1M | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice